Guest ArticlesZAKA VChealth tech A Drug Has to Answer 5 Questions, AI Made Only One Cheap. Who Pays for the Rest? A monthly column on biotech for founders and builders in Central and Eastern Europe. The first asks why cheaper design hasn't led to cheaper drugs. by Ján Búza
